| Health / Medical Topics |
PLK1 Inhibitor TAK-960
An orally available, Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity. Polo-like kinase 1 inhibitor TAK-960 selectively inhibits PLK1, inducing selective G2/M cell-cycle arrest followed by apoptosis in a variety of tumor cells while causing reversible cell-cycle arrest at the G1 and G2 stages without apoptosis in normal cells. PLK1 inhibition may result in the inhibition of proliferation in PLK1-overexpressed tumor cells. PLK1, named after the polo gene of Drosophila melanogaster, is a serine/threonine kinase crucial in the regulation of mitosis. (NCI Thesaurus)
YOU MAY ALSO LIKE
This gene plays a role in mitotic regulation.
A cyclic depsipeptide isolated from the marine tunicate Aplidium albicans. Plitidepsin displays a broad spectrum of antitumor activities, inducing apoptosis by triggering…
An epoch of the late Neogene period, from 5.3 to 1.8 million years before present.
An orally active diketopiperazine derivative with potential antineoplastic activity. Plinabulin selectively targets and binds to the colchicine-binding site of tubulin, thereby interrupting…
A drug used to treat some types of testicular cancer. It is also used to treat a higher-than-normal amounts of calcium in…
Human PLG wild-type allele is located in the vicinity of 6q26 is approximately 50 kb in length. This allele, which encodes plasminogen…
